BR102013030668B1 - composição para a preparação de ácido hialurônico reticulado viscoelástico e ácido hialurônico reticulado obtido por meio da utilização da mesma - Google Patents
composição para a preparação de ácido hialurônico reticulado viscoelástico e ácido hialurônico reticulado obtido por meio da utilização da mesma Download PDFInfo
- Publication number
- BR102013030668B1 BR102013030668B1 BR102013030668A BR102013030668A BR102013030668B1 BR 102013030668 B1 BR102013030668 B1 BR 102013030668B1 BR 102013030668 A BR102013030668 A BR 102013030668A BR 102013030668 A BR102013030668 A BR 102013030668A BR 102013030668 B1 BR102013030668 B1 BR 102013030668B1
- Authority
- BR
- Brazil
- Prior art keywords
- hyaluronic acid
- cross
- preparation
- composition
- crosslinked
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 128
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 127
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 126
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 15
- 238000004132 cross linking Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 230000002051 biphasic effect Effects 0.000 claims description 14
- 239000012670 alkaline solution Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 5
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical group C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 6
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 5
- 229940014041 hyaluronate Drugs 0.000 description 5
- 108010003272 Hyaluronate lyase Proteins 0.000 description 4
- 102000001974 Hyaluronidases Human genes 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 229960002773 hyaluronidase Drugs 0.000 description 4
- 230000010339 dilation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020130032956A KR101869988B1 (ko) | 2013-03-27 | 2013-03-27 | 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR102013030668A2 BR102013030668A2 (pt) | 2015-08-04 |
| BR102013030668A8 BR102013030668A8 (pt) | 2018-05-08 |
| BR102013030668B1 true BR102013030668B1 (pt) | 2020-04-07 |
Family
ID=51594442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR102013030668A BR102013030668B1 (pt) | 2013-03-27 | 2013-11-28 | composição para a preparação de ácido hialurônico reticulado viscoelástico e ácido hialurônico reticulado obtido por meio da utilização da mesma |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR101869988B1 (https=) |
| CN (2) | CN110078978A (https=) |
| AR (1) | AR093689A1 (https=) |
| BR (1) | BR102013030668B1 (https=) |
| IN (1) | IN2013MU03773A (https=) |
| MX (1) | MX366526B (https=) |
| MY (1) | MY169325A (https=) |
| RU (1) | RU2568998C2 (https=) |
| TR (1) | TR201313318A2 (https=) |
| TW (1) | TWI522134B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160268291A1 (en) * | 2015-03-13 | 2016-09-15 | Kabushiki Kaisha Toshiba | Semiconductor device and manufacturing method of semiconductor device |
| KR101720426B1 (ko) * | 2015-09-01 | 2017-04-14 | (주)시지바이오 | 히알루론산 조성물 및 그의 제조방법 |
| TWI708607B (zh) * | 2018-07-06 | 2020-11-01 | 南韓商Ｌｇ化學股份有限公司 | 同時具有高度黏彈性和內聚性之玻尿酸填料 |
| EP3804770B1 (en) * | 2018-07-10 | 2023-12-06 | Lg Chem, Ltd. | Hyaluronic acid filler having high lift capacity and low injection force |
| TWI797405B (zh) | 2018-12-21 | 2023-04-01 | 南韓商Ｌｇ化學股份有限公司 | 具有經改善之填充性質的包含玻尿酸水凝膠之填料 |
| KR102395184B1 (ko) * | 2020-03-10 | 2022-05-10 | (주)메디톡스 | 단일상도 아니고 이성상도 아닌 히알루론산 가교체, 및 이의 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827937A (en) * | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
| ATE221086T1 (de) * | 1995-11-15 | 2002-08-15 | Seikagaku Kogyo Co Ltd | Photovernetztes hyaluronsäuregel und verfahren zu dessen herstellung |
| FR2811996B1 (fr) * | 2000-07-19 | 2003-08-08 | Corneal Ind | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations |
| SE0401182D0 (sv) * | 2004-05-05 | 2004-05-05 | Q Med Ab | Novel use of a viscoelastic composition |
| KR101239037B1 (ko) * | 2004-11-15 | 2013-03-04 | 가부시키가이샤 시세이도 | 가교 히알루론산 겔의 제조 방법 |
| KR100852944B1 (ko) * | 2007-02-15 | 2008-08-19 | (주)아모레퍼시픽 | 화학적으로 가교된 히알루론산 하이드로겔 나노입자의제조방법 |
| CN101244290A (zh) * | 2007-11-30 | 2008-08-20 | 顾其胜 | 一种用于组织填充的交联透明质酸微粒凝胶的制备方法 |
| CN101538377A (zh) * | 2008-03-20 | 2009-09-23 | 上海昊海生物科技有限公司 | 一种交联透明质酸凝胶及其制备方法 |
| CN101759881A (zh) * | 2008-10-08 | 2010-06-30 | 上海建华精细生物制品有限公司 | 一种医用交联透明质酸钠凝胶衍生产品及其制备方法 |
| CN101724164B (zh) * | 2008-10-31 | 2011-12-14 | 科妍生物科技股份有限公司 | 交联透明质酸的制造方法 |
| CN102188712A (zh) * | 2010-03-04 | 2011-09-21 | 上海其胜生物制剂有限公司 | 一种可注射用凝胶微粒的制备方法 |
| CN102120833A (zh) * | 2011-01-10 | 2011-07-13 | 深圳市资福药业有限公司 | 一种透明质酸盐凝胶颗粒及其制备方法 |
| CN102952275A (zh) * | 2011-08-19 | 2013-03-06 | 上海建华精细生物制品有限公司 | 一种双相技术运用的透明质酸凝胶及其制备方法 |
-
2013
- 2013-03-27 KR KR1020130032956A patent/KR101869988B1/ko active Active
- 2013-11-13 TW TW102141213A patent/TWI522134B/zh active
- 2013-11-14 MY MYPI2013702159A patent/MY169325A/en unknown
- 2013-11-15 TR TR2013/13318A patent/TR201313318A2/tr unknown
- 2013-11-26 MX MX2013013828A patent/MX366526B/es active IP Right Grant
- 2013-11-28 BR BR102013030668A patent/BR102013030668B1/pt active IP Right Grant
- 2013-11-29 AR ARP130104435A patent/AR093689A1/es active IP Right Grant
- 2013-11-29 CN CN201811531607.7A patent/CN110078978A/zh active Pending
- 2013-11-29 CN CN201310631346.7A patent/CN104072814A/zh active Pending
- 2013-11-29 RU RU2013153007/13A patent/RU2568998C2/ru active
- 2013-12-02 IN IN3773MU2013 patent/IN2013MU03773A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013013828A (es) | 2014-09-26 |
| RU2013153007A (ru) | 2015-06-10 |
| CN104072814A (zh) | 2014-10-01 |
| TW201436827A (zh) | 2014-10-01 |
| CN110078978A (zh) | 2019-08-02 |
| BR102013030668A8 (pt) | 2018-05-08 |
| RU2568998C2 (ru) | 2015-11-20 |
| KR20140117956A (ko) | 2014-10-08 |
| BR102013030668A2 (pt) | 2015-08-04 |
| IN2013MU03773A (https=) | 2015-08-07 |
| TR201313318A2 (tr) | 2014-10-21 |
| AR093689A1 (es) | 2015-06-17 |
| TWI522134B (zh) | 2016-02-21 |
| KR101869988B1 (ko) | 2018-06-21 |
| MY169325A (en) | 2019-03-21 |
| MX366526B (es) | 2019-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102076337B1 (ko) | 히알루론산 유도체 및 dna 분획물이 포함된 히알루론산 주사용 조성물 및 이의 이용 | |
| BR102013030668B1 (pt) | composição para a preparação de ácido hialurônico reticulado viscoelástico e ácido hialurônico reticulado obtido por meio da utilização da mesma | |
| US8455465B2 (en) | Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine | |
| JP5517133B2 (ja) | 関節変性の治療のための注射用製剤の製造のための天然ポリサッカライドゲルの使用 | |
| ES2548187T3 (es) | Composición de ácido hialurónico que comprende un derivado del ácido ascórbico | |
| BR112015007772B1 (pt) | formulação aquosa estéril injetável contendo ácido hialurônico reticulado e de hidroxiapatita para uso estético | |
| TW201620496A (zh) | 具有改良抗性之多糖軟組織充填劑 | |
| KR20150015209A (ko) | 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도 | |
| RU2016105338A (ru) | Композиции с длительным высвобождением, полученные из гиалуроновой кислоты, и их терапевтические применения | |
| BRPI0820393B1 (pt) | Polissacarídeos ácidos, usos e processo para a preparação dos mesmos, bem como composições tópicas compreendendo os referidos polissacarídeos ácidos | |
| JP2023503894A (ja) | スルフヒドリル変性高分子化合物及びその調製方法並びに用途 | |
| EP3883618A1 (en) | Injectable composition including hyaluronic acid and use of the said composition | |
| JP2019532708A (ja) | 二価の亜鉛カチオンを含むヒアルロン酸ゲル | |
| KR102132478B1 (ko) | 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법 | |
| RS55633B1 (sr) | Fotoumreženi derivati hijaluronske kiseline, postupak njihovog pripremanja i upotreba | |
| ES2951115T3 (es) | Nueva disolución viscoelástica y su utilización en reumatología | |
| US20240207349A1 (en) | Gel for the regeneration of mucosae | |
| RU2454219C2 (ru) | Применение геля из природного полисахарида (природных полисахаридов) для приготовления годной для инъекции композиции при лечении дегенераций суставов | |
| CN105363075A (zh) | 一种用于止血和防粘连的可吸收医用材料及其制备方法 | |
| EP3142749A1 (en) | Viscosupplement composition comprising ulvan for treating arthritis | |
| KR20150046770A (ko) | 굴곡형 히알루론산 피복제 및 그 제조방법. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B25C | Requirement related to requested transfer of rights |
Owner name: LG LIFE SCIENCES LTD. (KR) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B25A | Requested transfer of rights approved |
Owner name: LG CHEM, LTD (KR) |
|
| B25E | Requested change of name of applicant rejected |
Owner name: LG CHEM, LTD (KR) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870170097579 DWE 13/12/2017, POR NAO SE TRATAR DE UMA ALTERACAO DE NOME E SIM DE UMA TRANSFERENCIA POR INCORPORACAO QUE JA FOI PUBLICADA NA RPI 2470 DE 08/05/2018. Owner name: LG CHEM, LTD (KR) |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/11/2013, OBSERVADAS AS CONDICOES LEGAIS. |